中国类风湿关节炎患者衰弱影响因素探索:定制评估工具验证
该横断面研究纳入1288例中国类风湿关节炎(RA)患者,对综合风湿病衰弱评估工具(CRAF)进行翻译和文化调适并验证其心理测量学特性,同时基于健康生态学理论通过多因素有序logistic回归识别与衰弱相关的因素。中文版CRAF信效度良好,且识别出病程、疼痛、躯体功能受限、用药及共病等多种衰弱相关因素。
要点
- 中文版CRAF在RA患者中信效度良好,Cronbach's α为0.75,ICC为0.92。
- CRAF与FRAIL量表显著正相关(P<0.001),且区分能力优于FRAIL量表(P=0.041)。
- 病程、疼痛、躯体功能受限、多种抗风湿药物及共病与衰弱显著相关。
核心结论
- 中文版CRAF是评估RA患者衰弱的可靠有效工具,针对已识别风险因素的干预可能有助于预防或延缓衰弱进展。
研究设计与样本
- 横断面研究,纳入1288例中国RA参与者,采用改良Brislin法对CRAF进行翻译和文化调适并评估心理测量学特性,基于健康生态学理论通过多因素有序logistic回归识别衰弱相关因素。
主要发现
- 中文版CRAF的Cronbach's α为0.75,组内相关系数为0.92,条目内容效度指数(CVI)范围为0.80至1.00,平均CVI为0.92。
- CRAF与FRAIL量表呈显著正相关(P<0.001),且CRAF的区分能力优于FRAIL量表(P=0.041)。
- 与衰弱显著相关的因素包括病程、疼痛强度、躯体功能受限、使用甲氨蝶呤、非甾体抗炎药、糖皮质激素和生物改善病情抗风湿药,以及高血压、糖尿病、心血管疾病、卒中/短暂性脑缺血发作、肺部疾病、握力下降、吸烟、抑郁和缺乏社会参与等共病。
关键数值与推荐
- 中文版CRAF的Cronbach's α为0.75,组内相关系数为0.92,条目CVI为0.80至1.00,平均CVI为0.92。
- CRAF与FRAIL量表显著正相关(P<0.001),CRAF区分能力优于FRAIL量表(P=0.041)。
临床怎么用
- 中文版CRAF可用于中国RA患者的衰弱评估,识别病程长、疼痛明显、躯体功能受限、使用特定抗风湿药物及合并共病等高危患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To identify the factors associated with frailty in Chinese participants with rheumatoid arthritis (RA), guided by the health ecology theory, and to provide a culturally adapted and psychometrically validated Chinese version of the Comprehensive Rheumatologic Assessment of Frailty (CRAF) to support context-specific assessments in clinical practice. METHODS: This cross-sectional study involved the translation and cultural adaptation of the CRAF using a modified Brislin method. Psychometric properties were evaluated, and factors associated with frailty were identified through multivariate ordered logistic regression, guided by the health ecology theory. RESULTS: A total of 1288 RA participants were recruited. The Cronbach's alpha for the Chinese CRAF was 0.75, and the intraclass correlation coefficient was 0.92. The Item-content validity index (CVI) ranged from 0.80 to 1.00, with an average CVI of 0.92. A significant positive correlation between the CRAF and the FRAIL Scale was found (P < 0.001), with the CRAF demonstrating better discriminatory power than the FRAIL scale (P = 0.041). Factors significantly associated with frailty included disease duration, pain intensity, limitations in physical function, the use of methotrexate, non-steroidal anti-inflammatory drugs, glucocorticoids, and biologic disease-modifying antirheumatic drugs, as well as comorbidities such as hypertension, diabetes, cardiovascular disease, stroke/transient ischemic attack, pulmonary disease, diminished grip strength, smoking, depression, and lack of social participation. CONCLUSION: The Chinese version of the CRAF is a reliable and valid tool for assessing frailty in RA participants. Targeted interventions addressing the identified risk factors may help prevent or delay frailty progression, ultimately improving prognosis and quality of life.
引用
- Ma B, Kan Y, Lv J, et al. Exploring factors contributing to frailty in Chinese patients with rheumatoid arthritis: Validation of a tailored assessment tool. Semin Arthritis Rheum. 2025. PMID: 41420997. doi:10.1016/j.semarthrit.2025.152896
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。